Pharmosa Biopharm Inc. (TPEX: 6875)
Taiwan
· Delayed Price · Currency is TWD 57.60
-1.60 (-2.70%)
Nov 21, 2024, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 7.34 billion as of November 22, 2024. Its market cap has decreased by -22.96% in one year.
Market Cap
7.34B
Enterprise Value
5.85B
Revenue
50.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.60
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 7.34B, an increase of 51.11%. That is a compound annual growth rate of 16.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 7.64B | -25.95% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition